Evidence map›Paper›PMID 37249711›Full record

ArticleWorld journal of microbiology & biotechnology2023

Antimicrobial activity of the Flo peptide produced in Scenedesmus acutus and Nannochloropsis oculata.

Saraí Damaris Dávalos-Guzmán, Fidel Martinez-Gutierrez, Luzmila Martínez-González, Jesús Josafath Quezada-Rivera, Ana Cecilia Lorenzo-Leal, Horacio Bach, José Francisco Morales-Domínguez, Ruth Elena Soria-Guerra

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Saraí Damaris Dávalos-GuzmánFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava No.6, Zona Universitaria, San Luis Potosí, C.P. 78210, México.ORCID http://orcid.org/0000-0002-1822-2432
Fidel Martinez-GutierrezFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava No.6, Zona Universitaria, San Luis Potosí, C.P. 78210, México.ORCID http://orcid.org/0000-0002-2760-8273
Luzmila Martínez-GonzálezFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava No.6, Zona Universitaria, San Luis Potosí, C.P. 78210, México.ORCID http://orcid.org/0000-0001-9942-6156
Jesús Josafath Quezada-RiveraUniversidad Juárez del Estado de Durango, Av. Universidad s/n, Fracc. Filadelfia, Gómez Palacio, Durango, CP. 35010, México.ORCID http://orcid.org/0000-0002-8519-6545
Ana Cecilia Lorenzo-LealDivision of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-2086-2412
Horacio BachDivision of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-7740-9299
José Francisco Morales-DomínguezUniversidad Autónoma de Aguascalientes, Av. Universidad No. 940, Ciudad Universitaria, Aguascalientes, Aguascalientes, C.P. 20100, México.ORCID http://orcid.org/0000-0003-3418-6416
Ruth Elena Soria-GuerraFacultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava No.6, Zona Universitaria, San Luis Potosí, C.P. 78210, México. ruth.soria@uaslp.mx.ORCID http://orcid.org/0000-0002-6801-4906
Autonomous University of San Luis Potosí · MXUniversity of British Columbia · CAAutonomous University of Aguascalientes · MXUniversidad Juárez del Estado de Durango · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuous increase of bacterial pathogen resistance to conventional antibiotics has challenged the research community to develop new antimicrobial strategies. Antimicrobial peptides (AMP) are a promising alternative to combat multidrug-resistant strains compared to conventional antibiotics because of their biocompatibility. In the present study, the Flo peptide, an AMP from the Moringa oleifera tree, was expressed in the chloroplast of the microalgae Nannochloropsis oculata and Scenedesmus acutus. The transgene insertion was verified by PCR amplification, and the homoplasmy was corroborated in spectinomycin-resistant lines. The identification and quantification of the peptide were performed using ELISA. The antimicrobial activity was studied against the Gram-negative Escherichia coli (ATCC 25,922) and Klebsiella pneumoniae (ATCC 700,603). The inflammatory response of the total soluble proteins of transplastomic N. oculata was assessed by measuring secretion of the cytokines IL-6, IL-10, and alpha-tumor necrosis (TNF-α), and cytotoxicity was assessed. These results provide a potential strategy to produce the Flo peptide in microalgae with antibacterial activities.

Indexed as

ScenedesmusStramenopilesAnti-Bacterial AgentsPeptidesAnti-Bacterial AgentsPeptidesAlgaeAntibacterialBiolisticChloroplast expressionMultidrug-resistanceNannochloropsis oculataScenedesmus acutus

Identifiers

PMID37249711
OpenAlexW4378745553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.